{"id":134899,"date":"2017-08-15T07:40:08","date_gmt":"2017-08-15T07:40:08","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=134899"},"modified":"2017-08-15T07:40:08","modified_gmt":"2017-08-15T07:40:08","slug":"boston-scientists-find-new-way-to-fight-pain","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/boston-scientists-find-new-way-to-fight-pain_134899.html","title":{"rendered":"Boston Scientists Find New Way To Fight Pain"},"content":{"rendered":"<div style=\"width:250px; font-weight:bold; font-style:italic;\" class=\"quotes\">\n<div>&#8220;In the future, this system could potentially combat that by giving patients access to nonopioid, effective nerve-blocking drugs.&#8221;<\/div>\n<\/div>\n<p style=\"text-align: justify;\">A team of scientists from the Boston Children&rsquo;s Hospital reportedly designed a new device meant to replace orally administered pain relievers. According to them, their idea will help people treat pain in the body locally and without any invasive procedures.<\/p>\n<p style=\"text-align: justify;\">Their findings were published last August 10 in the journal Nature Biomedical engineering. The scientists led by Dr. Daniel Kohane named their project &ldquo;<a rel=\"nofollow\" href=\"https:\/\/www.nature.com\/articles\/s41551-017-0117-6\" target=\"_blank\">Ultrasound-Triggered Local Anesthesia<\/a>.&rdquo; They believe their invention could one day improve the lives of many people by permanently replacing addictive narcotics used as pain relievers.<\/p>\n<p style=\"text-align: justify;\">&#8220;Opioid abuse is a growing problem in healthcare,&#8221; said Kohane. The doctor is a senior associate in critical care medicine at Boston Children&#8217;s. He also teaches at the Harvard Medical School on the subject of anesthesiology.<\/p>\n<p style=\"text-align: justify;\">&#8220;In the future, this system could potentially combat that by giving patients access to nonopioid, effective nerve-blocking drugs.&#8221;<\/p>\n<p style=\"text-align: justify;\">The study showcases a device that uses ultrasound waves to trigger nerve-blocking agents within the patient. The anesthesia is initially injected by doctors on specific sites where the pain is usually felt on the body before the procedure begins.<\/p>\n<p style=\"text-align: justify;\">&#8220;One of the most interesting aspects of this system is that the degree of nerve block can be controlled just by adjusting the duration and intensity of the ultrasound,&rdquo; said Alina Rwei, a graduate researcher in Dr. Kohane&#8217;s laboratory. &#8220;We envision that patients could get an injection at the hospital and then bring home a small, portable ultrasound device for triggering the nerve-blocking agent. This could allow patients to manage their pain relief at-will, noninvasively.&#8221;<\/p>\n<p style=\"text-align: justify;\">The system involves tiny sacs that filled with nerve-blocking drugs; this is then injected into the patient through a syringe. Each sac is around a micrometer in diameter. The walls of this sac are composed of sono-sensitizers which are organic materials sensitive to ultrasound.<\/p>\n<p style=\"text-align: justify;\">&#8220;Once the drug-filled liposomes are injected, ultrasound can be applied to penetrate tissue and cause the sensitizers to create reactive oxygen species, which react with lipids in the walls of the liposomes,&#8221; Dr. Kohane added. &#8220;This opens the surface of the liposomes and releases the nerve-blocking drug into the local tissue, reducing pain.&#8221;<\/p>\n<p style=\"text-align: justify;\">&#8220;Out of all the particle delivery systems, I think liposomes are one of the most clinically acceptable and customizable options out there,&#8221; Ms. Rwei concluded. &#8220;Our research indicates that liposomes can be tailored to respond to near-infrared light, ultrasound, and even magnetic triggers.&#8221;<\/p>\n<p style=\"text-align: justify;\">The need for alternative pain relief systems is amplified due to the increasing abuse rate of various narcotic drugs such as Tramadol. One of the <a rel=\"nofollow\" href=\"https:\/\/www.drug.education\/opiates\/tramadol\/side-effects-tramadol\/\">side effects of long term use of Tramadol<\/a> may result to addiction which can become a life long struggle for many patients.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> The Nation Today<br \/><strong>Contact Person:<\/strong> Michael R. Thrasher<br \/><strong>Email:<\/strong> michael@thenation.today<br \/><strong>Phone:<\/strong> (866) 954-1189<br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> NV<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.thenation.today\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.thenation.today\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.thenation.today\/\" style=\"width:605px; height:400px;\"><\/object><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=boston-scientists-find-new-way-to-fight-pain\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8220;In the future, this system could potentially combat that by giving patients access to nonopioid, effective nerve-blocking drugs.&#8221; A team of scientists from the Boston Children&rsquo;s Hospital reportedly designed a new device meant to replace orally administered pain relievers. According &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/boston-scientists-find-new-way-to-fight-pain_134899.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-134899","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/134899","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=134899"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/134899\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=134899"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=134899"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=134899"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}